Email Us : info@kisumu.go.ke | Toll Free Number: 0800 720 575

County Government of Kisumu

  • Home
  • About Us
    • Kisumu County
    • Visit Kisumu
  • County Structure
    • County Executive Members
      • County Executive Members 2022 – 2027
    • County Assembly
    • City of Kisumu
    • County Departments
  • Resources
    • Downloads
    • Public Service Board
    • Job Vacancies
    • International Trade Procedures
    • Speeches and Press Releases
    • County Newsletters
    • Quick Links
      • County-Pro
      • E-Citizen
      • County HelpDesk
      • Visit Kisumu
    • Projects
    • Tenders
    • Gallery
      • Videos
      • Photos
  • News
  • Contact Us
STAFFMAIL

LEARNING MORE ABOUT CORONA VIRUS.

Friday, 04 February 2022 / Published in Uncategorized

LEARNING MORE ABOUT CORONA VIRUS.

by Lorraine Anyango

Staff members from Jaramogi Oginga Odinga Teaching and referral hospital (JOOTRH) undertaking Continuous Medical Education (CME) on validation of the WHO COVID-19 verbal autopsy tool.

The staff members drawn from different departments were being trained by Washington State University on the tool that will be used for determining cause of death in Kenya during the COVID 19 Pandemic.

The validation of the tool will be done through a study that will be conducted at JOOTRH to know the actual causes of death during COVID-19 pandemic.

The study notes that death registration have declined in 2020 [~35.9%; was 39.1% in 2019] and they are speculative or undocumented in many cases, also people not seeking medical care out of fear or COVID-19 stigma.

There is abridged medical workup in suspected or confirmed COVID-19 cases, most respiratory syndromes designated COVID-19 and reliable data is crucial for health planning and prioritization and designing better interventions and programs hence better population health.

The objective of the study is to assess the sensitivity, specificity, and level of agreement of the WHO Verbal Autopsy COVID-19 tool in ascertaining COVID 19 mortality and comparison with a reference standard cause of death (COD) from medical records.

The tool has not been validated for widespread use in low- and middle-income countries where there is sub-optimal access to COVID-19 testing.

The six months study will be conducted at JOOTRH, Siaya County Referral, Busia County referral and all sub-counties where deaths of close relative living within 50km of the study facility are reported.

The importance of mortality data comprises monitoring the health of the population, knowing the leading causes of death, establishing mortality rates (geographic variations) and trends over time.

It informs decisions about health policy and strategy, prevent premature deaths, service provision, health budgets and evaluate health service outcomes.

During the training the staff learnt that Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) , a new strain that has not been previously identified in humans.  

They were also informed that as coronaviruses are zoonotic, meaning they are transmitted between animals and people and that common signs of infection include: Respiratory symptoms, Fever, Shortness of breath and breathing difficulties.

As at January 2022, a total number of corona virus infections stood at 379.1 million with 5.692 million deaths worldwide. While Kenya has registered 321,381 cases with 5,583 deaths, new cases in the last 28 days in Kenya stands at 189/21649 which is 0.87% of infections.

Taking the participants through the training Dr. Dismas Oketch, Mortality Surveillance Technical Officer, Washington State University-GH Kenya, said that all viruses, including SARS-CoV-2, change over time.

He added that most changes have little to no impact on the virus’ properties. However, some changes may affect the virus’s properties, such as ease of spread, disease severity, performanceof vaccines, medicines & diagnostic tools, or other public health and social measures. 

Dr Oketch stated that WHO, in collaboration with partners, have been monitoring and assessing the evolution of SARS-CoV-2 since January 2020.  

Dr Oketch further told the participants that the variants if interest  (voi) has genetic changes that are predicted or known to affect virus characteristics such as transmissibility, disease severity, immune escape, diagnostic or therapeutic escape and causing significant community transmission or multiple COVID-19 clusters.

The above has been witnessed in multiple countries with increasing relative prevalence alongside increasing number of cases over time.​

The participants were informed that Omicron is the current dominant strain, it has a high infection rate, shorter incubation period of 3 days compared to delta variant which takes 4 days and 5 days compared to previous variants.

Omicron replicates well in upper airways, however it has poor replication in lower airway in lung cells, it’s a less severe disease and it seems able to get around immunity (infection & vaccine)

“The vaccine still prevents severe disease and booster shots reduce risk of infection by half.” Dr Oketch added.

The participants also were trained on Flurona and that it entails infection with flu and corona viruses at once and it’s seen mostly in the unvaccinated and children under five years with symptoms largely the same including headache, fatigue, fever, cough and it’s potentially any riskier than the individual diseases.

Currently there are two types of tests available, the viral test which includes rapid Ag test, rapid or lab (PCR) and the current infection. The antibody test include serology and past infection.

The treatment available for corona virus include dexamethasone administered when the disease is severe disease and one is hospitalized.

“Corona virus is also treated using Toclizumab which is administered to patients aged two and above with severe disease, receiving corticosteroids and it dampens immune response.” Dr Oketch said. 

Other treatments include remdesivir administered to patients aged two years and above with the disease being severe the treatment increases recovery time.

Bactricinib is also available and it’s combined with Remdesivir, when one requires respiratory support

“Doctors also administer anti-coagulants to reduce the risk of clots.

There are orther newer drugs including two pills approved for treatment in US (FDA), which come into use on 22nd Dec 2021, Pfizer. For patients who are 12 years and above For persons with mild to moderate disease at risk of severe disease. The drugs are only prescribed to be used only, within five days of symptom onset. They reduced risk of hospitalization and death by 88% by day 28.

The Molnupiravir drugs started being used on 23 Dec 2021, Merck, used with those with mild to moderate disease at risk of severe disease, used within five  days of symptom onset and it reduces risk of hospitalization and death by 30% by 29 day.

Share this Post

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020

Kisumu Neurosurgical Camp

Kisumu County Facebook Feeds

County Government of Kisumu

Kisumu County Twitter Feed

Tweets by KisumuCountyKE

Quick Links

  • Careers
  • Tenders
  • Projects
  • Staff Mails
  • County Assembly
  • E-Services
  • County Pro
  • E-Citizen

Quick Links

  • Careers
  • Tenders
  • Projects
  • Staff Mails
  • County Assembly
  • E-Services
  • County Pro
  • E-Citizen

County Government of Kisumu

We transform the livelihood of the people of Kisumu county on a foundation of integrity through accountable, efficient and effective leadership that invokes participation and pursuit of quality services, for a prosperous county that is a harbor of excellence

Get In Touch

Prosperity House (Former Nyanza Provincial Headquarters Building)
P.O. Box 2738-40100, Kisumu.
Email: info@kisumu.go.ke
Website: www.kisumu.go.ke

Quick Links

  • Job Vacancies
  • Downloads
  • Tenders
  • County Assembly
  • Staff Mail
  • County News
  • E-services
  • E-Citizen
  • County Pro
  • 100% Renewables Roadmap
  • County Helpdesk System

Kisumu County Twitter feed

Tweets by KisumuCountyKE

© 2022 All rights reserved. County Government of Kisumu.

TOP